Literature DB >> 20886187

The dengue virus envelope protein induced PAI-1 gene expression via MEK/ERK pathways.

Huey-Wen Shyu1, Yi-Ying Lin, Lien-Cheng Chen, Yi-Fen Wang, Trai-Ming Yeh, Shu-Jem Su, Wei-Cheng Cheng, Chang-Yu Chen, Kuan-Hua Lin, Miao-Chen Chou.   

Abstract

Dengue virus (DV) infections cause mild dengue fever or severe life-threatening dengue haemorrhagic fever (DHF)/ dengue shock syndrome (DSS). DV-infected patients have high plasma concentrations of plasminogen activator inhibitor type I (PAI-1). However, the mechanism to cause haemorrhage in DV infections remains poorly understood. In this study, investigation was carried out on the purified recombinant domain III of the envelope glycoprotein of DV serotypes 2 (EIII) and the signalling pathways of EIII leading to PAI-1 gene expression were measured by RT-PCR, Western blot, and immunofluorescence stain. Reporter gene constructs containing serially 5'-deleted sequences of the proximal human PAI-1 promoter region were constructed and then transfected to Huh7 cells, a human hepatoma cell line, prior to EIII treatment. EIII increased the PAI-1 mRNA and protein levels in a dose-dependent manner in Huh7 cells. Results showed that U0126, an inhibitor of extracellular signal-regulated kinase (ERK) kinase (MEK), almost completely suppressed EIII-induced PAI-1 expression. The results suggest that the MEK/ERK signalling pathways mediate the EIII-dependent induction of PAI-1 gene expression via the proximal promoter region.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20886187     DOI: 10.1160/TH10-05-0302

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans.

Authors:  Julia Koch-Heier; Annika Schönsiegel; Lara Maria Waidele; Julian Volk; Yvonne Füll; Christian Wallasch; Sebastian Canisius; Michael Burnet; Oliver Planz
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

2.  Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling.

Authors:  Jessica L Smith; David A Stein; David Shum; Matthew A Fischer; Constantin Radu; Bhavneet Bhinder; Hakim Djaballah; Jay A Nelson; Klaus Früh; Alec J Hirsch
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

3.  Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through Interaction with Vitronectin and Terminal Complement Proteins.

Authors:  Jonas Nascimento Conde; Emiliana Mandarano da Silva; Diego Allonso; Diego Rodrigues Coelho; Iamara da Silva Andrade; Luciano Neves de Medeiros; Joice Lima Menezes; Angela Silva Barbosa; Ronaldo Mohana-Borges
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

Review 4.  Highlights in antiviral drug research: antivirals at the horizon.

Authors:  Erik De Clercq
Journal:  Med Res Rev       Date:  2012-05-02       Impact factor: 12.944

5.  Evaluation of Prognostic Values of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Crimean-Congo Hemorrhagic Fever Patients.

Authors:  Yunus Gurbuz; Baris Ozturk; Emin Ediz Tutuncu; Irfan Sencan; Gonul Cicek Senturk; Fatma Aybala Altay
Journal:  Jundishapur J Microbiol       Date:  2015-10-20       Impact factor: 0.747

6.  Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2-dependent pathway.

Authors:  Danhui Liu; Yuzhen Liu; Bo Qi; Chengwei Gu; Shuhua Huo; Baosheng Zhao
Journal:  Cancer Med       Date:  2021-06-23       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.